Radical radiation therapy in the treatment of laparotomy staged Hodgkin's disease patients
Journal Article
·
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
In 1970 a policy for the treatment of Stage IIIA Hodgkin's disease patients at the University of Minnesota, which included complete staging procedures and extended field or total nodal irradiation (TNI), was introduced. Evaluation of the results 4 years later indicated that certain patients, especially those with large mediastinal masses and/or hilar disease, or who were spleen positive, were having higher recurrence rates than patients without these characteristics. In 1974, a new approach to treatment for patients with large mediastinal masses or spleen positive disease was instituted which involved treating the whole lung or hemi lung in patients with large mediastinal masses and/or hilar disease, and the liver in patients who had positive spleens. The results of this treatment modification are reported in this study. Long term follow-up reveals that this approach has led to a recurrence free survival and overall survival similar to that noted in patients treated with combined modality treatment without the obvious risk of subsequent leukemia related to combination chemotherapy and radiotherapy. In addition, the complications of the treatment are tolerable and do not demonstrate an increase over patients not treated in this manner. Radical radiation therapy is recommended as a treatment of choice for Stage IA, IIA, and IIIA patients with or without splenic involvement, and with or without hilar disease and/or large mediastinal masses with appropriate radiation field modification to adjust for disease extent.
- Research Organization:
- Univ. of Minnesota Health Sciences Center, Minneapolis
- OSTI ID:
- 7133453
- Journal Information:
- Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 10:2; ISSN IOBPD
- Country of Publication:
- United States
- Language:
- English
Similar Records
Liver irradiation in stage IIIA Hodgkin's disease patients with splenic involvement
Treatment selection for stage IIIA Hodgkin's disease patients
Therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses
Journal Article
·
Sat Mar 31 23:00:00 EST 1984
· Am. J. Clin. Oncol.; (United States)
·
OSTI ID:6849171
Treatment selection for stage IIIA Hodgkin's disease patients
Journal Article
·
Thu Aug 01 00:00:00 EDT 1985
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:5323095
Therapeutic utility of lung irradiation for Hodgkin's disease patients with large mediastinal masses
Conference
·
Sat Jan 31 23:00:00 EST 1981
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6792830
Related Subjects
550603 -- Medicine-- External Radiation in Therapy-- (1980-)
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BODY AREAS
CHEST
DELAYED RADIATION EFFECTS
DISEASES
DOSES
EXTERNAL IRRADIATION
HODGKINS DISEASE
IRRADIATION
LUNGS
LYMPHOMAS
MEDIASTINUM
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PARTIAL BODY IRRADIATION
PATIENTS
PNEUMONITIS
RADIATION DOSES
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
THERAPY
560151* -- Radiation Effects on Animals-- Man
62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
BIOLOGICAL EFFECTS
BIOLOGICAL RADIATION EFFECTS
BODY
BODY AREAS
CHEST
DELAYED RADIATION EFFECTS
DISEASES
DOSES
EXTERNAL IRRADIATION
HODGKINS DISEASE
IRRADIATION
LUNGS
LYMPHOMAS
MEDIASTINUM
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
ORGANS
PARTIAL BODY IRRADIATION
PATIENTS
PNEUMONITIS
RADIATION DOSES
RADIATION EFFECTS
RADIOINDUCTION
RADIOLOGY
RADIOTHERAPY
RESPIRATORY SYSTEM
SIDE EFFECTS
THERAPY